Our approach to bioresilience

Biodefense in the Intelligence Age

An action plan for AI-powered biological resilience

Announcing our partnership with the Republic of Korea

Google DeepMind and Korea partner to accelerate scientific breakthroughs using frontier AI models

Strengthening Singapore’s AI Future: A New National Partnership

Google DeepMind and Singapore partner to apply frontier AI to address complex challenges across health, education, and sustainability and more.

Investing in multi-agent AI safety research

Google DeepMind and partners announce a $10M funding call for multi-agent safety research.

Protecting people from harmful manipulation

Google DeepMind researches AI's harmful manipulation risks across areas like finance and health, leading to new safety measures.

Partnering with industry leaders to accelerate AI transformation

Google DeepMind partners with global consultancies to bring the power of frontier AI to organizations around the world.

Google DeepMind supports U.S. Department of Energy on Genesis: a national mission to accelerate innovation and scientific discovery

Google DeepMind and the DOE partner on Genesis, a new effort to accelerate science with AI.

Google DeepMind and A24 announce first-of-its-kind research partnership

Deepening our partnership with the UK AI Security Institute

Google DeepMind and UK AI Security Institute (AISI) strengthen collaboration on critical AI safety and security research

Measuring AI’s capability to accelerate biological research

OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both the promise and risks of AI-assisted experimentation.

MedGemma: Our most capable open models for health AI development

We’re announcing new multimodal models in the MedGemma collection, our most capable open models for health AI development.

Preparing for future AI risks in biology

Advanced AI can transform biology and medicine—but also raises biosecurity risks. We’re proactively assessing capabilities and implementing safeguards to prevent misuse.